Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

1.

Outcome of various treatments for posttransplant hepatitis B virus recurrence.

Yi NJ, Lee KW, Kong SY, Park KU, Lee KB, Hong G, Han SS, Park SJ, Suh KS.

World J Surg. 2013 Apr;37(4):812-9. doi: 10.1007/s00268-013-1914-z.

PMID:
23344522
[PubMed - indexed for MEDLINE]
2.

Potent hepatitis B surface antigen response to treatment of hepatitis-B-e-antigen-positive chronic hepatitis B with α-interferon plus a nucleos(t)ide analog.

Chen X, Cao Z, Liu Y, Zhang H, Zhang Y, Ma L, Jin Y, Yu H, Ma B, Zheng Y, Wu H.

J Gastroenterol Hepatol. 2012 Mar;27(3):481-6. doi: 10.1111/j.1440-1746.2011.06970.x.

PMID:
22098411
[PubMed - indexed for MEDLINE]
3.

Patterns of hepatitis B surface antigen decline and HBV DNA suppression in Asian treatment-experienced chronic hepatitis B patients after three years of tenofovir treatment.

Seto WK, Liu K, Wong DK, Fung J, Huang FY, Hung IF, Lai CL, Yuen MF.

J Hepatol. 2013 Oct;59(4):709-16. doi: 10.1016/j.jhep.2013.06.007. Epub 2013 Jun 17.

PMID:
23792029
[PubMed - indexed for MEDLINE]
4.

Hepatitis B prophylaxis post liver transplantation with newer nucleos(t)ide analogues after hepatitis B immunoglobulin discontinuation.

Cholongitas E, Vasiliadis T, Antoniadis N, Goulis I, Papanikolaou V, Akriviadis E.

Transpl Infect Dis. 2012 Oct;14(5):479-87. doi: 10.1111/j.1399-3062.2012.00741.x. Epub 2012 May 25.

PMID:
22624695
[PubMed - indexed for MEDLINE]
5.

Sustained responses and loss of HBsAg in HBeAg-negative patients with chronic hepatitis B who stop long-term treatment with adefovir.

Hadziyannis SJ, Sevastianos V, Rapti I, Vassilopoulos D, Hadziyannis E.

Gastroenterology. 2012 Sep;143(3):629-36.e1. doi: 10.1053/j.gastro.2012.05.039. Epub 2012 May 31.

PMID:
22659218
[PubMed - indexed for MEDLINE]
6.

Low risk of hepatitis B virus recurrence after withdrawal of long-term hepatitis B immunoglobulin in patients receiving maintenance nucleos(t)ide analogue therapy.

Wong SN, Chu CJ, Wai CT, Howell T, Moore C, Fontana RJ, Lok AS.

Liver Transpl. 2007 Mar;13(3):374-81.

PMID:
17318855
[PubMed - indexed for MEDLINE]
Free Article
7.

Kinetics and prediction of HBsAg loss during therapy with analogues in patients affected by chronic hepatitis B HBeAg negative and genotype D.

Boglione L, D'Avolio A, Cariti G, Gregori G, Burdino E, Baietto L, Cusato J, Ghisetti V, De Rosa FG, Di Perri G.

Liver Int. 2013 Apr;33(4):580-5. doi: 10.1111/liv.12091. Epub 2013 Jan 14.

PMID:
23311449
[PubMed - indexed for MEDLINE]
8.

Liver transplantation for chronic hepatitis B with lamivudine-resistant YMDD mutant using add-on adefovir dipivoxil plus lamivudine.

Lo CM, Liu CL, Lau GK, Chan SC, Ng IO, Fan ST.

Liver Transpl. 2005 Jul;11(7):807-13.

PMID:
15973721
[PubMed - indexed for MEDLINE]
Free Article
9.

Oral nucleoside/nucleotide analogs without hepatitis B immune globulin after liver transplantation for hepatitis B.

Fung J, Chan SC, Cheung C, Yuen MF, Chok KS, Sharr W, Chan AC, Cheung TT, Seto WK, Fan ST, Lai CL, Lo CM.

Am J Gastroenterol. 2013 Jun;108(6):942-8. doi: 10.1038/ajg.2013.111. Epub 2013 Apr 30.

PMID:
23629601
[PubMed - indexed for MEDLINE]
10.

Prevention of de novo hepatitis B in recipients of core antibody-positive livers with lamivudine and other nucleos(t)ides: a 12-year experience.

Chang MS, Olsen SK, Pichardo EM, Stiles JB, Rosenthal-Cogan L, Brubaker WD, Guarrera JV, Emond JC, Brown RS Jr.

Transplantation. 2013 Apr 15;95(7):960-5. doi: 10.1097/TP.0b013e3182845f97.

PMID:
23545507
[PubMed - indexed for MEDLINE]
11.

Long-term outcome of renal transplant recipients with chronic hepatitis B infection-impact of antiviral treatments.

Yap DY, Tang CS, Yung S, Choy BY, Yuen MF, Chan TM.

Transplantation. 2010 Aug 15;90(3):325-30. doi: 10.1097/TP.0b013e3181e5b811.

PMID:
20562676
[PubMed - indexed for MEDLINE]
12.

Predictors of relapse in chronic hepatitis B after discontinuation of anti-viral therapy.

Liang Y, Jiang J, Su M, Liu Z, Guo W, Huang X, Xie R, Ge S, Hu J, Jiang Z, Zhu M, Wong VW, Chan HL.

Aliment Pharmacol Ther. 2011 Aug;34(3):344-52. doi: 10.1111/j.1365-2036.2011.04738.x. Epub 2011 Jun 14.

PMID:
21671967
[PubMed - indexed for MEDLINE]
13.

Is there an association between the measurement of qualitative HBsAg and virologic response in chronic HBV infection?

Altinbas A, Aktas B, Basar O, Yüksel O, Ekiz F, Yilmaz B, Coban S.

Ann Hepatol. 2012 May-Jun;11(3):320-5.

PMID:
22481449
[PubMed - indexed for MEDLINE]
14.

[Factors associated with response to lamivudine: retrospective study of 233 patients with chronic hepatitis B].

Zhou HJ, Li SG, Wen FY, Yang XY, Wu JL, Tan B, Fu J.

Zhonghua Gan Zang Bing Za Zhi. 2009 Aug;17(8):564-8. Chinese.

PMID:
19719911
[PubMed - indexed for MEDLINE]
15.

Adefovir and lamivudine in combination compared with adefovir monotherapy in HBeAg-negative adults with chronic hepatitis B virus infection and clinical or virologic resistance to lamivudine: a retrospective, multicenter, nonrandomized, open-label study.

Pellicelli AM, Barbaro G, Francavilla R, Romano M, Barbarini G, Mazzoni E, Mecenate F, Paffetti A, Barlattani A, Struglia C, Villani R, Nauri L, Nosotti L, Armignacco O, Ferri F, Camporiondo MP, Soccorsi F; Club Epatologi Ospedalieri (CLEO) Group.

Clin Ther. 2008 Feb;30(2):317-23. doi: 10.1016/j.clinthera.2008.02.012.

PMID:
18343270
[PubMed - indexed for MEDLINE]
16.

Adefovir dipivoxil therapy in liver transplant recipients for recurrence of hepatitis B virus infection despite lamivudine plus hepatitis B immunoglobulin prophylaxis.

Akyildiz M, Karasu Z, Zeytunlu M, Aydin U, Ozacar T, Kilic M.

J Gastroenterol Hepatol. 2007 Dec;22(12):2130-4.

PMID:
18031370
[PubMed - indexed for MEDLINE]
17.

Safety and efficacy of adefovir therapy for lamivudine-resistant hepatitis B virus infection in renal transplant recipients.

Lai HW, Chang CC, Chen TH, Tsai MC, Chen TY, Lin CC.

J Formos Med Assoc. 2012 Aug;111(8):439-44. doi: 10.1016/j.jfma.2011.05.010. Epub 2012 Apr 30.

PMID:
22939662
[PubMed - indexed for MEDLINE]
18.

Nucleoside analogues improve the short-term and long-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure.

Chen T, He Y, Liu X, Yan Z, Wang K, Liu H, Zhang S, Zhao Y.

Clin Exp Med. 2012 Sep;12(3):159-64. doi: 10.1007/s10238-011-0160-7. Epub 2011 Oct 15.

PMID:
22002708
[PubMed - indexed for MEDLINE]
19.

Entecavir monotherapy is effective in suppressing hepatitis B virus after liver transplantation.

Fung J, Cheung C, Chan SC, Yuen MF, Chok KS, Sharr W, Dai WC, Chan AC, Cheung TT, Tsang S, Lam B, Lai CL, Lo CM.

Gastroenterology. 2011 Oct;141(4):1212-9. doi: 10.1053/j.gastro.2011.06.083. Epub 2011 Jul 14.

PMID:
21762659
[PubMed - indexed for MEDLINE]
20.

Nucleos(t)ide analogues only induce temporary hepatitis B e antigen seroconversion in most patients with chronic hepatitis B.

Reijnders JG, Perquin MJ, Zhang N, Hansen BE, Janssen HL.

Gastroenterology. 2010 Aug;139(2):491-8. doi: 10.1053/j.gastro.2010.03.059. Epub 2010 Apr 8.

PMID:
20381492
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk